High Pines Wealth Management’s Amgen AMGN Stock Holding History

High Pines Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$223K	Sell	775 -100	-11%	-$27.2K	0.34%	30
2023 Q3	$235K	Sell	875 -400	-31%	-$99.8K	0.39%	29
2023 Q2	$283K	Buy	1,275 +2	+0.2%	+$464	0.43%	26
2023 Q1	$308K	Buy	1,273 +11	+0.9%	+$2.7K	0.51%	25
2022 Q4	$331K	Hold	1,262	–	–	0.58%	20
2022 Q3	$284K	Sell	1,262 -311	-20%	-$75.4K	0.54%	22
2022 Q2	$383K	Sell	1,573 -9,953	-86%	-$2.44M	0.71%	13
2022 Q1	$2.79M	Buy	11,526 +990	+9%	+$227K	2.05%	24
2021 Q4	$2.37M	Sell	10,536 -8,331	-44%	-$1.76M	1.65%	26
2021 Q3	$4.01M	Buy	18,867 +2,748	+17%	+$632K	2.75%	18
2021 Q2	$3.93M	Buy	16,119 +243	+2%	+$59.8K	2.96%	16
2021 Q1	$3.95M	Buy	15,876 +7,351	+86%	+$1.75M	3.49%	11
2020 Q4	$1.96M	Buy	+8,525	New	+$1.97M	1.81%	23

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

High Pines Wealth Management's AMGN Position: Q4 2023 in Review

High Pines Wealth Management reduced its Amgen (AMGN) stake by 11% in Q4 2023, selling an estimated $27.2K and leaving 775 shares worth $223K. The position accounts for 0.34% of the portfolio, ranked #30.

High Pines Wealth Management first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.01M in Q3 2021. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

High Pines Wealth Management held 775 shares of Amgen worth $223K as of Q4 2023.
High Pines Wealth Management sold 100 Amgen shares in Q4 2023, an estimated $27.2K.
Amgen made up 0.34% of High Pines Wealth Management's portfolio in Q4 2023, its #30 holding.
High Pines Wealth Management first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
High Pines Wealth Management's Amgen position peaked at $4.01M in Q3 2021.
2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on High Pines Wealth Management's 13F filing for Q4 2023, filed 12 Jan 2024.